• CIPLA QUALITY CHEMICAL INDUSTRIES

  • XUGA_CQCIL KAMPALA/Uganda
Refreshing....

Keep track of your investments easily

MoneyInAfrica removes the hassle of keeping track your investment.
My Portfolio enables you to monitor the performance of your investments on an easy-to-use fully online system.

Understand how your investments are performing with daily price and currency updates, optional email alerts regarding dividends and corporate actions such as dividends and share splits.

 

 

 

SUBSCRIBE NOW

 

Already a subscriber, LOGIN below

Don't miss out on a promising investment, keep it on your radar

MoneyinAfrica simplifies the process of watching promising investments.

My Watchlist enables you to watch investments on an easy-to-use fully online system.

Keeping tabs on those promising investments is optional emails alerts regarding new financial results and significant price changes

 

 

 

REGISTER NOW

 

Already a subscriber, LOGIN below

CiplaQCIL is a WHO-certified, cGMP-compliant pharmaceutical manufacturing company founded by 4 Ugandan Entrepreneurs and works with a world class technical partner, Cipla Limited of India. It was started 13 years ago with an entirely African manufacturing base.
The Company currently concentrates on the manufacture of WHO recommended treatments of three of Africa’s most terrible diseases, HIV/AIDS, malaria and hepatitis B, and will soon manufacture a cure for hepatitis C. CiplaQCIL is the only WHO cGMP-compliant pharmaceutical plant in Sub-Saharan Africa (SSA) that manufactures WHO-prequalified first-line treatments for both HIV/AIDS and malaria. The CiplaQCIL facility is now approved in 13 countries (compared to eight countries in March 2016), and ambition is to be registered in 19 SSA countries by December 2020.

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

KEY STOCK DATA

  • Profits (TTM)
  • $1.81M
  • P/E Ratio
  • 68.28
  • Return on Equity
  • 4.03%
  • Dividend Yield
  • %
FINANCIAL ANALYSIS
flip phone to landscape for better view
Revenue per year in US $
Revenue is the money a company recieves for selling its goods or providing services. The higher the revenue, the better the company is performing.

Compare with;

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

Subscribe for premium content

Subscribe for more analysis and insights, investment calculators and ability to make your own watchlist.

 

SUBSCRIBE NOW

Already a subscriber, LOGIN below

NEWS

CiplaQCIL to go public